𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson’s disease

✍ Scribed by Tomoko Oeda; Motoko Masaki; Kenji Yamamoto; Eiji Mizuta; Naoyuki Kitagawa; Tsuyoshi Isono; Satoshi Taniguchi; Kiyoshi Doi; Hitoshi Yaku; Chikao Yutani; Takashi Kawamura; Sadako Kuno; Hideyuki Sawada

Publisher
Springer
Year
2008
Tongue
English
Weight
245 KB
Volume
116
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Valvular heart disease in Parkinson's di
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists
✍ Ji-Youn Kim; Eun Joo Chung; Seung Woo Park; Won Yong Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

Valvular heart disease, associated with ergot derivative dopamine agonists, has been reported in patients with Parkinson's disease (PD). There are few comparative studies on the frequency, severity, and dose dependency of valvular disease associated with ergot derivatives. We analyzed these factors

Valvular heart disease in Parkinson's di
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader-blinded monocenter echocardiography study
✍ Susann Junghanns; Joerg T. Fuhrmann; Gregor Simonis; Christian Oelwein; Rainer K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

## Abstract Fibrotic valvular heart disease (VHD) has been reported in association with ergot dopamine agonists (DAs), but the current database is insufficient regarding clinical relevance and comparison to data on non‐ergot DAs. We evaluated the effects of four DAs (pergolide, cabergoline, ropinir

The risk of valvular regurgitation in pa
The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists
✍ Vibeke Guldbrand Rasmussen; Karen Østergaard; Erik Dupont; Steen Hvitfeldt Pouls 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

## Abstract ## Objectives: Several observational studies suggest an association between treatment with ergoline‐derived dopamine agonists and valvular regurgitation. In this article, we present an overview of the literature and conduct a meta‐analysis. ## Methods: Observational studies addressin